In France, Amoéba announces its 2020 half-year results which were in line with those of 2019 and continues to develop its biocide and biocontrol applications, albeit with some areas slightly delayed such as the application for the marketing of the biocide activity in the United States, previously planned for mid-2020 is postponed and will be […]
In France, Amoeba, a pioneer of amoeba- based technologies for the biocide and plant protection markets signed an evaluation and testing agreement with Syngenta, one of the world’s leaders in agriculture. In response to the growing demand for effective and sustainable solutions against fungal diseases, Syngenta will test different concepts based on Amoeba’s Willaertia magna […]
In France, AMOEBA, producer of a biological biocide capable of eliminating bacterial risk in water and human wounds, and a biocontrol product for plant protection, still in trial phase, announces that a new application for approval of its biocidal active substance Willaertia magna C2c Maky has been submitted to the European Chemical Agency (ECHA). If […]
In France, Amoéba, producer of a biological biocide, still in the testing phase, capable of eliminating bacterial risk in water and human wounds, and a bio-control product for plant protection, announced an efficacy of its amoeba lysate Willaertia magna C2c Maky in the field against grapevine downy mildew. The intermediate results of the 13 field […]
